Chugai: Polivy approved for treatment of relapsed or refractory diffuse large B-cell lymphoma in Japan

Dear Investor, Please find attached a press release by Chugai:https://www.roche.com/dam/jcr:886cf513-18db-4809-a7d5-de8b66ca4b0e/en/210324_IR_Chugai_ePolivy_Approval.pdf Do not hesitate to contact us for any further questions. With best regards,
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news